SARS-CoV-2 spike protein expression as an identification in quality control testing for Adenovector based COVID-19 vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 spike protein expression as an identification in quality control testing for Adenovector based COVID-19 vaccine

Published:2024-06 Issue: Volume:529 Page:113680
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Kasana Harit,Ade Ajay Kumar,Meena Jaipal,Sayal Archana,Sheikh Faraz,Anvikar Anupkumar R.,Chander Harish

Publisher

Elsevier BV

Reference12 articles.

1. Emerging prophylaxis strategies against COVID-19. Monaldi archives for chest disease;Agrawal;Arch. Monaldi Malattie Torace,2020

2. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Coronaviridae Study Group of the International Committee on Taxonomy of Viruses;Nat. Microbiol.,2020

3. Landscape of novel coronavirus candidate vaccine development worldwide;COVID-19,2022

4. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial;Ella;Lancet Infect. Dis.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP